« Previous
Next »
Titles
- A premium support system for Medicare: updated analysis of illustrative options1
- An evaluation of CBO's past outlay projections1
- CBO's long-term Social Security projections: changes since 2017 and comparisons with the Social Security trustees' projections1
- Changes to CBO's long-term Social Security projections since 20161
- Child well-being: key considerations for policymakers including the need for a federal cross-agency priority goal : a report to Congress1
- Counternarcotics: overview of U.S. efforts in the Western Hemisphere : report to the ranking member, Committee on Foreign Affairs, House of Representatives1
- Drug control policy: information on status of federal efforts and key issues for preventing illicit drug use : testimony before the Committee on Oversight and Government Reform, House of Representatives1
- Drug discount program: update on agency efforts to improve 340B program oversight : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives1
- Drug industry: profits, research and development spending, and merger and acquisition deals : report to Congressional requesters1
- Employment of people ages 55 to 791
- Exploring the growth of Medicaid managed care1
- FDA medical device reviews: evaluation is needed to assure requests for additional information follow a least burdensome approach : report to Congressional requestors1
- Federal employees health benefits program: enrollment remains concentrated despite more plan offerings, and effects of adding plan types are uncertain : report to the ranking member, Committee on Oversight and Government Reform, House of Representatives1
- Federal mandatory spending for means-tested programs, 2008 to 20281
- Federal mandatory spending for means-tested programs: 2009 to 20291
- Federal subsidies for health insurance coverage for people under age 65: 2017 to 20271
- Health benefits in retirement: set for extinction?1
- Health insurance coverage for people under age 65: definitions and estimates for 2015 to 20181
- How CBO adjusts for survey underreporting of transfer income in its distributional analyses1
- Increases in reimbursement for brand-name drugs in Part D1